Cite

HARVARD Citation

    Duric, N. et al. (2020). A Novel Marker, Based on Ultrasound Tomography, for Monitoring Early Response to Neoadjuvant Chemotherapy. Journal of breast imaging. 2 (6), pp. 569-576. [Online]. 
  
Back to record